Nuvaira
Signal active
Organization
Contact Information
Overview
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease.
It was founded in 2008 and headquartered in Minneapolis, Minnesota.
About
Industries
Information Technology, Biotechnology, Health Care, Medical Device
Founded
2008
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Nuvaira headquartered in United States, North America, operates in the Information Technology, Biotechnology, Health Care, Medical Device sector. The company focuses on Information Technology and has secured $35.9B in funding across 176 round(s). With a team of 51-100 employees, Nuvaira is actively contributing to advancements in Information Technology. Their latest funding round, Series D - Nuvaira, raised $42.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
11
Investors
7
Lead Investors
0
Total Funding Amount
$204.0M
Details
7
Nuvaira has raised a total of $204.0M in funding over 7 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2012 | Early Stage Venture | 10.6M | ||
| 2010 | Early Stage Venture | 3.0M | ||
| 2013 | Late Stage Venture | 10.0M | ||
| 2014 | Late Stage Venture | 42.0M |
Investors
Nuvaira is funded by 46 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Nuvaira | - | FUNDING ROUND - Nuvaira | 10.0M |
| Versant Ventures | - | FUNDING ROUND - Versant Ventures | 10.0M |
| Nuvaira | - | FUNDING ROUND - Nuvaira | 42.0M |
| Vertex Ventures | - | FUNDING ROUND - Vertex Ventures | 42.0M |
Recent Activity
There is no recent news or activity for this profile.